High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor

Heterotrimeric guanine nucleotide–binding protein (G protein)–coupled receptors constitute the largest family of eukaryotic signal transduction proteins that communicate across the membrane. We report the crystal structure of a human β2-adrenergic receptor–T4 lysozyme fusion protein bound to the partial inverse agonist carazolol at 2.4 angstrom resolution. The structure provides a high-resolution view of a human G protein–coupled receptor bound to a diffusible ligand. Ligand-binding site accessibility is enabled by the second extracellular loop, which is held out of the binding cavity by a pair of closely spaced disulfide bridges and a short helical segment within the loop. Cholesterol, a necessary component for crystallization, mediates an intriguing parallel association of receptor molecules in the crystal lattice. Although the location of carazolol in the β2-adrenergic receptor is very similar to that of retinal in rhodopsin, structural differences in the ligand-binding site and other regions highlight the challenges in using rhodopsin as a template model for this large receptor family.

[1]  R. Stevens,et al.  GPCR Engineering Yields High-Resolution Structural Insights into β2-Adrenergic Receptor Function , 2007, Science.

[2]  M. Burghammer,et al.  Crystal structure of the human β2 adrenergic G-protein-coupled receptor , 2007, Nature.

[3]  Xavier Deupi,et al.  Conformational complexity of G-protein-coupled receptors. , 2007, Trends in pharmacological sciences.

[4]  Richard N. Zare,et al.  A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein , 2007, Proceedings of the National Academy of Sciences.

[5]  M R G Taylor,et al.  Pharmacogenetics of the human beta-adrenergic receptors , 2007, The Pharmacogenomics Journal.

[6]  B. Kobilka,et al.  Dosage‐dependent switch from G protein‐coupled to G protein‐independent signaling by a GPCR , 2007, The EMBO journal.

[7]  Wei Liu,et al.  In meso structure of the cobalamin transporter, BtuB, at 1.95 A resolution. , 2006, Journal of molecular biology.

[8]  Krzysztof Palczewski,et al.  Crystal structure of a photoactivated deprotonated intermediate of rhodopsin , 2006, Proceedings of the National Academy of Sciences.

[9]  Shaomeng Wang,et al.  Computational elucidation of the structural basis of ligand binding to the dopamine 3 receptor through docking and homology modeling. , 2006, Journal of medicinal chemistry.

[10]  Krzysztof Palczewski,et al.  G protein-coupled receptor rhodopsin. , 2006, Annual review of biochemistry.

[11]  David W. Ritchie,et al.  Modeling the Structural Basis of Human CCR5 Chemokine Receptor Function: From Homology Model Building and Molecular Dynamics Validation to Agonist and Antagonist Docking , 2006, J. Chem. Inf. Model..

[12]  Andrei L. Lomize,et al.  OPM: Orientations of Proteins in Membranes database , 2006, Bioinform..

[13]  Yang Zhang,et al.  Structure Modeling of All Identified G Protein–Coupled Receptors in the Human Genome , 2006, PLoS Comput. Biol..

[14]  M. Nowak,et al.  Homology modeling of the serotonin 5-HT1A receptor using automated docking of bioactive compounds with defined geometry. , 2006, Journal of medicinal chemistry.

[15]  T. Schwartz,et al.  Molecular mechanism of 7TM receptor activation--a global toggle switch model. , 2006, Annual review of pharmacology and toxicology.

[16]  B. Kobilka,et al.  Using synthetic lipids to stabilize purified beta2 adrenoceptor in detergent micelles. , 2005, Analytical biochemistry.

[17]  G. Schertler Structure of rhodopsin and the metarhodopsin I photointermediate. , 2005, Current opinion in structural biology.

[18]  Robert J. Lefkowitz,et al.  Transduction of Receptor Signals by ß-Arrestins , 2005, Science.

[19]  Jonathan A Javitch,et al.  The Ants Go Marching Two by Two: Oligomeric Structure of G-Protein-Coupled Receptors , 2004, Molecular Pharmacology.

[20]  Avinash Peddi,et al.  Electronic Reprint Biological Crystallography a Robotic System for Crystallizing Membrane and Soluble Proteins in Lipidic Mesophases Biological Crystallography a Robotic System for Crystallizing Membrane and Soluble Proteins in Lipidic Mesophases , 2022 .

[21]  S. Green,et al.  A Primate-dominant Third Glycosylation Site of the β2-Adrenergic Receptor Routes Receptors to Degradation during Agonist Regulation* , 2004, Journal of Biological Chemistry.

[22]  Marcus Elstner,et al.  The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure. , 2004, Journal of molecular biology.

[23]  P. Insel,et al.  The evolving role of lipid rafts and caveolae in G protein‐coupled receptor signaling: implications for molecular pharmacology , 2004, British journal of pharmacology.

[24]  Christopher A Reynolds,et al.  Toward the active conformations of rhodopsin and the β2‐adrenergic receptor , 2004, Proteins.

[25]  Graeme Milligan,et al.  G Protein-Coupled Receptor Dimerization: Function and Ligand Pharmacology , 2004, Molecular Pharmacology.

[26]  P. Yeagle,et al.  Structural studies of the putative helix 8 in the human beta(2) adrenergic receptor: an NMR study. , 2004, Biochimica et biophysica acta.

[27]  Peter L. Freddolino,et al.  Predicted 3D structure for the human beta 2 adrenergic receptor and its binding site for agonists and antagonists. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Duan Yang,et al.  The evolution of transmembrane helix kinks and the structural diversity of G protein-coupled receptors. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Manfred Burghammer,et al.  Structure of bovine rhodopsin in a trigonal crystal form. , 2003, Journal of molecular biology.

[30]  T. Bai Beta2 adrenergic receptors in asthma: A current perspective , 2004, Lung.

[31]  E. Landau,et al.  Structural and mechanistic insight from high resolution structures of archaeal rhodopsins , 2003, FEBS letters.

[32]  Terry P Lybrand,et al.  Three-dimensional models for beta-adrenergic receptor complexes with agonists and antagonists. , 2003, Journal of medicinal chemistry.

[33]  H. Schiöth,et al.  The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. , 2003, Molecular pharmacology.

[34]  Lei Shi,et al.  The Fourth Transmembrane Segment Forms the Interface of the Dopamine D2 Receptor Homodimer* , 2003, The Journal of Biological Chemistry.

[35]  Didier Rognan,et al.  Protein‐based virtual screening of chemical databases. II. Are homology models of g‐protein coupled receptors suitable targets? , 2002, Proteins.

[36]  Jean-François Mercier,et al.  Quantitative Assessment of β1- and β2-Adrenergic Receptor Homo- and Heterodimerization by Bioluminescence Resonance Energy Transfer* , 2002, The Journal of Biological Chemistry.

[37]  J. Ballesteros,et al.  Beta2 adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by a rotamer toggle switch. , 2002, The Journal of biological chemistry.

[38]  B. Kobilka,et al.  Caveolar Localization Dictates Physiologic Signaling of β2-Adrenoceptors in Neonatal Cardiac Myocytes* , 2002, The Journal of Biological Chemistry.

[39]  S. Mitaku,et al.  Identification of G protein‐coupled receptor genes from the human genome sequence , 2002, FEBS letters.

[40]  K. Palczewski,et al.  Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.

[41]  W. Delano The PyMOL Molecular Graphics System , 2002 .

[42]  J. Rosenbusch,et al.  Molecular mechanism for the crystallization of bacteriorhodopsin in lipidic cubic phases , 2001, FEBS letters.

[43]  Nathan A. Baker,et al.  Electrostatics of nanosystems: Application to microtubules and the ribosome , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[44]  J. Ballesteros,et al.  The Forgotten Serine , 2000, The Journal of Biological Chemistry.

[45]  M. Caffrey,et al.  A lipid's eye view of membrane protein crystallization in mesophases. , 2000, Current opinion in structural biology.

[46]  R. Lefkowitz The superfamily of heptahelical receptors , 2000, Nature Cell Biology.

[47]  S. Angers,et al.  Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[48]  J. Drews Drug discovery: a historical perspective. , 2000, Science.

[49]  U. Gether Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. , 2000, Endocrine reviews.

[50]  J. Ashby References and Notes , 1999 .

[51]  D. Rohrer Physiological consequences of β-adrenergic receptor disruption , 1998, Journal of Molecular Medicine.

[52]  M. Grossmann,et al.  G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.

[53]  B. Kobilka,et al.  Adrenergic Receptors From Molecular Structure to in vivo function. , 1997, Trends in cardiovascular medicine.

[54]  J. Rosenbusch,et al.  Lipidic cubic phases: a novel concept for the crystallization of membrane proteins. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[55]  Michel Bouvier,et al.  A Peptide Derived from a β2-Adrenergic Receptor Transmembrane Domain Inhibits Both Receptor Dimerization and Activation* , 1996, The Journal of Biological Chemistry.

[56]  R. Smiley,et al.  Do receptors get pregnant too? Adrenergic receptor alterations in human pregnancy. , 1996, The Journal of maternal-fetal medicine.

[57]  G. Milligan,et al.  Why are there so many adrenoceptor subtypes? , 1994, Biochemical pharmacology.

[58]  R. Graham,et al.  The high affinity state of the beta 2-adrenergic receptor requires unique interaction between conserved and non-conserved extracellular loop cysteines. , 1994, The Journal of biological chemistry.

[59]  A. Strosberg,et al.  Structure, function, and regulation of adrenergic receptors , 1993, Protein science : a publication of the Protein Society.

[60]  M. Caron,et al.  Catecholamine receptors: structure, function, and regulation. , 1993, Recent progress in hormone research.

[61]  P. Barnes Beta-adrenoceptors on smooth muscle, nerves and inflammatory cells. , 1993, Life sciences.

[62]  B. Kobilka,et al.  Adrenergic receptors as models for G protein-coupled receptors. , 1992, Annual review of neuroscience.

[63]  C. Strader,et al.  Identification of two serine residues involved in agonist activation of the beta-adrenergic receptor. , 1989, The Journal of biological chemistry.

[64]  J Deisenhofer,et al.  Nobel lecture. The photosynthetic reaction centre from the purple bacterium Rhodopseudomonas viridis. , 1989, The EMBO journal.

[65]  M. Caron,et al.  Palmitoylation of the human beta 2-adrenergic receptor. Mutation of Cys341 in the carboxyl tail leads to an uncoupled nonpalmitoylated form of the receptor. , 1989, The Journal of biological chemistry.

[66]  C. Strader,et al.  Conserved aspartic acid residues 79 and 113 of the beta-adrenergic receptor have different roles in receptor function. , 1988, The Journal of biological chemistry.

[67]  A. Soulairac [Adrenergic receptors]. , 1966, La Presse medicale.